Cipla Gets US Regulatory nod for New Drug
Global drug major Cipla Ltd announced on Friday that it had received approval of the United States Food and Drug Administration (USFDA) for its new drug Darifenacin tablets for treating bladder symptoms.
"The generic tablet in 7.5mg and 15 mg (dose) are used for treating overactive bladder with symptoms of urge in urinary incontinence, urgency and frequency," said the city-based company in a statement here.
The new drug is AB-rated generic equivalent of Allergan's Enablex tablets. The company will launch the product soon.
Get live Nifty Future Tips News Updates visit us : http://www.ripplesadvisory.com/nifty-future-.php or Get Two Days Free Trial just on One Missed Call @98-27-80-80-90
Global drug major Cipla Ltd announced on Friday that it had received approval of the United States Food and Drug Administration (USFDA) for its new drug Darifenacin tablets for treating bladder symptoms. 
No comments:
Post a Comment